Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
OHSU Knight Cancer Institute, Portland, Oregon UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas